ZIOPHARM Oncology Q3 EPS $(0.43) May Not Compare To $(0.09) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.09) by 377.78 percent. This is a 230.77 percent decrease over losses of $(0.13) per share

Benzinga · 11/07/2019 21:45

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.09) by 377.78 percent. This is a 230.77 percent decrease over losses of $(0.13) per share from the same period last year.